Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $28 from $32 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the consumer staples group as part of a Q1 preview. Barclays has “growing caution” on the group into the prints due to higher input costs. In food, there are now “building concerns” around the sustainability of the dividend for certain companies, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $35 from $38 at BofA
- Keurig Dr Pepper price target lowered to $37 from $40 at Wells Fargo
- Keurig Dr Pepper price target lowered to $32 from $36 at UBS
- Keurig Dr Pepper resumed with an In Line at Evercore ISI
- Keurig Dr Pepper Completes Landmark JDE Peet’s Acquisition
